MET and nasopharyngeal carcinoma: Although several studies have evaluated the frequency and prognostic value of MET overexpression in NPC, the results of these studies are highly variable, with MET overexpression rates ranging from 51.5% to 91.1%, and some studies even reporting that MET had no significant prognostic value [28–30].